Fibroblast growth factor 23–secreting pancreaticobiliary malignancy-Reference-Cited by-同舟云学术

Fibroblast growth factor 23–secreting pancreaticobiliary malignancy

Published:2018-02 Issue:1 Volume:2 Page:21-23
ISSN:2399-3693
Container-title:Journal of Onco-Nephrology
language:en
Short-container-title:Journal of Onco-Nephrology

Author:

Barta Valerie¹,Lalkiya Neel²,Phan Huy²,Miller Ilene³,Sachdeva Mala³

Affiliation:

1. Lenox Hill Hospital, Northwell Health, New York, NY, USA

2. Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA

3. Division of Kidney Diseases and Hypertension, Northwell Health, Great Neck, NY, USA

Abstract

Malignancy-related tumor-induced osteomalacia is a rare but important entity. We report the first case of oncogenic renal phosphate wasting in the setting of a pancreaticobiliary malignancy. Our patient presented with refractory hypophosphatemia. Workup revealed high fibroblast growth factor 23 levels as well as a new pancreaticobiliary mass. All other causes of hypophosphatemia were ruled out. With tumor-induced osteomalacia, an accurate diagnosis and location of the offending tumor is essential for appropriate management and treatment.

Publisher

SAGE Publications

Link

http://journals.sagepub.com/doi/pdf/10.1177/2399369318776177

Reference14 articles.

1. Advanced prostate cancer as a cause of oncogenic osteomalacia: an underdiagnosed condition

2. Tumour induced hypophosphataemia associated with small cell carcinoma of the bronchus.

3. Ovarian Cancer-Related Hypophosphatemic Osteomalacia—A Case Report

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-Induced Osteomalacia in Patients With Malignancy: A Meta-analysis and Systematic Review of Case Reports;The Journal of Clinical Endocrinology & Metabolism;2023-05-26

2. Prognostic Value of Serum Soluble Klotho and Fibroblast Growth Factor-23 in Multiple Myeloma Patients;Indian Journal of Hematology and Blood Transfusion;2021-07-13